Page last updated: 2024-10-25

clomipramine and Experimental Leukemia

clomipramine has been researched along with Experimental Leukemia in 2 studies

Clomipramine: A tricyclic antidepressant similar to IMIPRAMINE that selectively inhibits the uptake of serotonin in the brain. It is readily absorbed from the gastrointestinal tract and demethylated in the liver to form its primary active metabolite, desmethylclomipramine.
clomipramine : A dibenzoazepine that is 10,11-dihydro-5H-dibenzo[b,f]azepine which is substituted by chlorine at position 3 and in which the hydrogen attached to the nitrogen is replaced by a 3-(dimethylamino)propyl group. One of the more sedating tricyclic antidepressants, it is used as the hydrochloride salt for the treatment of depression as well as obsessive-compulsive disorder and phobias.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19902 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Tsuruo, T2
Iida, H2
Nojiri, M1
Tsukagoshi, S2
Sakurai, Y2

Other Studies

2 other studies available for clomipramine and Experimental Leukemia

ArticleYear
Potentiation of chemotherapeutic effect of vincristine in vincristine resistant tumor bearing mice by calmodulin inhibitor clomipramine.
    Journal of pharmacobio-dynamics, 1983, Volume: 6, Issue:2

    Topics: Animals; Calmodulin; Clomipramine; Drug Resistance; Drug Synergism; Drug Therapy, Combination; Leuke

1983
Increased accumulation of vincristine and adriamycin in drug-resistant P388 tumor cells following incubation with calcium antagonists and calmodulin inhibitors.
    Cancer research, 1982, Volume: 42, Issue:11

    Topics: Animals; Calcium Channel Blockers; Calcium-Binding Proteins; Calmodulin; Clomipramine; Doxorubicin;

1982